A- A A+

Köln. Häftling bekam versehentlich Methadon und bricht zusammen

Ein 23-Jähriger ist in Untersuchungshaft zusammengebrochen. Er hatte versehentlich Methadon bekommen. Der Fall beschäftigt jetzt den Landtag. (WR – Westfälische Rundschau, 11.02.2019)


USA. When Going to Jail Means Giving Up The Meds That Saved Your Life

How the Americans With Disabilities Act could change the way the nation’s jails and prisons treat addiction. (The Marshall Project, USA, 29.01.2019)


USA. Federal Judge Issues Groundbreaking Order to a Jail to Allow Methadone Access

A federal court judge has stated that denying medication-assisted treatment (MAT) to an incarcerated person would “likely” be found unconstitutional. The judge ordered that a plaintiff should have continued access to MAT while he is held in jail for the duration of the case. (FILTER, USA, 27.11.2018)


Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use.

Winkelman TNA, Chang VW, Binswanger IA.

JAMA Netw Open. 2018 Jul 6;1(3):e180558. doi: 10.1001/jamanetworkopen.2018.0558.


FREE WEBINAR: How to deliver effective opioid substitute treatment in prisons - Monday 10th December 7 p.m.

How to deliver effective opioid substitute treatment in prisons

This webinar will focus on:

- overcoming organisational and cultural issues,

- stabilisation and assisted withdrawal,

- retox and continuity of care

Dr Joss Bray - Clinical Lead for Drug and Alcohol Treatment in the North East Prisons for Spectrum CIC.
Dr Jake Hard - HMP Eastwood Park and HMP Leyhill, Hanham Health surgery. Chair of the RCGP Secure Environments Group.
Tamara Healey - Non-Medical Prescriber, Substance Misuse, Eastwood Park Prison, Bristol Community Health. (SMMGP - Supporting good practice in drug and alcohol treatment, UK, 05.11.2018)


Medicine in the Penal System.

Opitz-Welke A, Lehmann M, Seidel P, Konrad N.

Dtsch Arztebl Int. 2018 Nov 30;115(48):808-814. doi: 10.3238/arztebl.2018.0808.


Schadensmindernde Maßnahmen beim intravenösen Drogenkonsum im Strafvollzug (Deutscher Bundestag. Drucksache19/5225, 19. Wahlperiode, 19.10.2018)

Antwort der Bundesregierung auf die Kleine Anfrage der Abgeordneten Niema Movassat, Dr. André Hahn, Gökay Akbulut, weiterer Abgeordneter und der Fraktion DIE LINKE. 

– Drucksache 19/4712 – 

Schadensmindernde Maßnahmen beim intravenösen Drogenkonsum im Strafvollzug 


Köln. Verheerende Wirkung: Sanitäter reicht Methadon an den falschen Häftling in JVA Köln 

(Kölner Stadt Anzeiger, 31.01.2019)


Suchtbehandlung im Vollzug: Ministerium weicht Fragen zur Opioid-Substitution im Gefängnis aus

Erhalten Opioid-Abhängige in deutschen Gefängnissen eine leitliniengerechte Behandlung? Danach erkundigte sich vor einigen Tagen die Linksfraktion im Bundestag in einer Kleinen Anfrage. Die meisten Teilfragen zur Versorgungssituation ließ das Bundesministerium für Justiz und Verbraucherschutz unbeantwortet. (DAZ – Deutsche Apotheker Zeitung, 22.10.2018)


Bayern. Kalter Entzug: Drogensüchtige in bayerischen Gefängnissen

Wegen Handels mit Betäubungsmitteln musste sich ein Häftling der JVA Kaisheim vor dem Augsburger Amtsgericht verantworten. In bayerischen Gefängnissen werden Drogensüchtige kaum mit Ersatzstoffen wie Methadon behandelt. Dadurch floriert der Handel. (Bayerischer Rundfunk, BR24, 24.01.2019)


USA. At Rikers Island, a Legacy of Medication-Assisted Opioid Treatment 

NEW YORK — For Dr. Ross MacDonald, every person who enters New York City’s main jail with an opioid addiction represents an opportunity for treatment, and the possibility of saving a life. 

As the medical director of the city’s correctional health program, he ensures that offenders who come in on methadone continue to receive it. And he and his staff try to persuade as many addicted inmates as possible to get started on methadone before they leave the jail. (Pew Trust, USA, 23.05.2016)


Understanding HIV and hepatitis C virus risk among incarcerated young men with histories of injecting drug use

Walker, Shelley et al.

The Lancet Infectious Diseases , Volume 19 , Issue 2 , 130 - 131 


Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration.

Crowley D, Van Hout MC, Murphy C, Kelly E, Lambert JS, Cullen W.

Health Justice. 2018 Dec 19;6(1):23. doi: 10.1186/s40352-018-0081-6.


WHO / UNODC. Treatment and care for people with drug use disorders in contact with the criminal justice system - Alternatives to Conviction or Punishment

Draft pre-launch publication for initial circulation.

United Nations Office on Drugs and Crime, March 2018. World Health Organization, March 2018


Incarceration, drug use, and infectious diseases: a syndemic still not addressed

Zaller, Nickolas et al.

The Lancet Infectious Diseases , Volume 0 , Issue 0 , 

Published:October 29, 2018, doi.org/10.1016/S1473-3099(18)30538-3


Outcomes of treatment for hepatitis C in prisoners using a nurse-led, state-wide model of care.

Papaluca T, McDonald L, Craigie A, Gibson A, Desmond P, Wong D, Winter R, Scott N, Howell J, Doyle J, Pedrana A, Lloyd A, Stoove M, Hellard M, Iser D, Thompson A.

J Hepatol. 2019 Jan 14. pii: S0168-8278(19)30024-8. doi: 10.1016/j.jhep.2019.01.012.



Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis

Stone, Jack et al.

The Lancet Infectious Diseases , Volume 0 , Issue 0 , Published: October 29, 2018, doi.org/10.1016/S1473-3099(18)30469-9


Initiating methadone in jail and in the community: Patient differences and implications of methadone treatment for reducing arrests.

Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O'Grady KE, Jaffe JH.

J Subst Abuse Treat. 2019 Feb;97:7-13. doi: 10.1016/j.jsat.2018.11.006. 



USA. Pennsylvania DOC to Pilot Injectable Buprenorphine for Detoxing Prisoners

The Pennsylvania Department of Corrections is moving to reduce Suboxone diversion in its prisons by giving inmates suffering from opioid withdrawal an injectable form of the treatment drug buprenorphine. The plan may even make a dent in the state’s annual toll of more than 5,000 overdose deaths. (Filter, USA, 12.10.2018)


Restoring something lost -- The mental health impact of therapy dogs in prisons (REPORT)

Dr Graham Durcan, Centre for Mental Health, UK, 2018


Rheinland-Pfalz will Designerdrogen im Gefängnis aufspüren

Ein Brief mit Kokain, Methadon in Augentropfen oder eine Designerdroge im Papier: Drogen finden auf unterschiedlichste Weise in den Knast. Das will die JVA Wittlich gemeinsam mit dem Justizministerium und dem LKA in Rheinland-Pfalz verhindern. (Welt, 17.10.2018)


USA. Caught in Chaos—When Pregnant Women With OUD Are Incarcerated; How OTPs Can Help

This is the story of a young woman with a 15-year history of severe opioid use disorder (OUD), intermittent hospitalization, and incarceration, who becomes pregnant. She has a history of trauma and mental health issues, and few social supports. Her story is the subject of a case report recently published in the Journal of Addiction Medicine. (ATForum, USA, 17.12.2018)


Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.

Azbel L, Wegman MP, Polonsky M, Bachireddy C, Meyer J, Shumskaya N, Kurmanalieva A, Dvoryak S, Altice FL.

Int J Prison Health. 2018 Sep 10;14(3):175-187. doi: 10.1108/IJPH-03-2017-0016.



Baden-Württemberg. Einheitliche Behandlungsweise gewünscht: Sozialausschuss befasst sich mit der Suchtrehabilitation von Gefangenen

Stuttgart. „Der Justizvollzug stellt kein geeignetes Umfeld zur Überwindung einer Abhängigkeitserkrankung dar.“ Dies erklärte der Vorsitzende des Ausschusses für Soziales und Integration, Rainer Hinderer (SPD), in der Sitzung am Donnerstag, 6. Dezember. Der Ausschuss hat sich auf Antrag der Grünen und der CDU mit der Suchtrehabilitation Gefangener befasst. „Eine in Haft eingeleitete medizinische Rehabilitation erhöht die Chance auf ein drogen- und straffreies Leben“, berichtete Hinderer. (Landtag von Baden-Württemberg, Pressemitteilung 132/2018, 06.12.2018)


Pakistan’s HIV Epidemic and the Need for Prison-Based Harm Reduction Programmes

Faryal Sajjad

GDPO Situation Analysis, October 2018


Barriers and facilitators to hepatitis C (HCV) screening and treatment—a description of prisoners’ perspective

Des Crowley, Marie Claire Van Hout, John S. Lambert, Enda Kelly, Carol Murphy and Walter Cullen

Harm Reduction Journal 2018, 15:62, doi.org/10.1186/s12954-018-0269-z


European evidence-based guidance on prevention and control of HCV in prison settings (poster)


In the 31 EU/EEA countries, more than 590 000 persons are held in a custodial facility on any given day. According to recent reviews of prison studies from EU countries, prison prevalence estimates for HCV ranged from 4.3 % to 86.3 %.

People in prison also tend to have multiple complex health and social care needs resulting from a mix  of specific socio-economic determinants and environmental factors. A significant proportion of people in prison have a history of drug use, and a strong association has been found between prison history and HCV prevalence in people who inject drugs.

Prisons are settings of increased risk for HCV transmission, while representing a unique opportunity to address the healthcare needs of those people in prison who belong to hard-to-reach and medically underserved groups in the community, such as people who inject drugs. (EMCDDA,ECDC,Lisasbon,September 2018)


Medizin im Justizvollzug - Medicine in the penal system

Dtsch Arztebl Int 2018; 115(48): 808-14; DOI: 10.3238/arztebl.2018.0808

Opitz-Welke, Annette; Lehmann, Marc; Seidel, Peter; Konrad, Norbert


USA. Law And Order: How the Smallest State is Defeating America’s Biggest Addiction Crisis 

Rhode Island inmates get opioid replacements while they’re locked up and it seems to be keeping them from overdosing when they get out. (Politico Magazine, USA, 25.08.2018)


High im Knast: Häftlinge erhalten nur selten eine Substitutionstherapie 

Welche schadensmindernden Maßnahmen beim intravenösen Drogenkonsum im Justizvollzug könnten einer Überdosis oder der Ansteckung mit Infektionskrankheiten entgegenwirken? Das wollten Politiker der Linken-Fraktion im Bundestag von der Bundesregierung wissen. Die Antwort war wenig aussagekräftig. (Medical Tribune, 02.12.2018)